1887

Journal of General Virology header logo

Volume 88, Issue 4

Experimental infection of macaques with human metapneumovirus induces transient protective immunity Free

Abstract

(hMPV), a member of the family , is a causative agent of acute respiratory-tract illness. Two main hMPV lineages circulate worldwide and reinfections occur frequently. It is unclear what level of protection is induced by natural hMPV infection, what the durability of this protection is and whether it differs for reinfection with homologous or heterologous viruses. Here, protective immunity in cynomolgus macaques at different time points after inoculation with molecularly cloned prototype viruses of the two main lineages of hMPV has been addressed. Animals received a homologous challenge at 4, 6 or 12 weeks after the primary infection. In addition, animals that had been inoculated three times within 10 weeks were challenged with homologous or heterologous virus 8 months later. Primary infection with 10 TCID resulted in virus shedding and induction of virus-neutralizing antibody responses, with higher titres against the homologous than the heterologous virus. Infections associated with virus shedding and seroconversion protected completely from homologous reinfection within 6 weeks, and partly at 12 weeks, after primary infection. Eight months later, protection had waned to virtually undetectable levels. This study demonstrates that experimental hMPV infection induces transient protective immunity.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82663-0
2007-04-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/4/1251.html?itemId=/content/journal/jgv/10.1099/vir.0.82663-0&mimeType=html&fmt=ahah

References

  1. Biacchesi S., Skiadopoulos M. H., Tran K. C., Murphy B. R., Collins P. L., Buchholz U. J. 2004a; Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 321:247–259 [CrossRef]
     [Google Scholar]
  2. Biacchesi S., Skiadopoulos M. H., Yang L., Lamirande E. W., Tran K. C., Murphy B. R., Collins P. L., Buchholz U. J. 2004b; Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78:12877–12887 [CrossRef]
     [Google Scholar]
  3. Biacchesi S., Pham Q. N., Skiadopoulos M. H., Murphy B. R., Collins P. L., Buchholz U. J. 2005; Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2–2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 79:12608–12613 [CrossRef]
     [Google Scholar]
  4. Buchholz U. J., Biacchesi S., Pham Q. N., Tran K. C., Yang L., Luongo C. L., Skiadopoulos M. H., Murphy B. R., Collins P. L. 2005; Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J Virol 79:6588–6597 [CrossRef]
     [Google Scholar]
  5. Chanock R. M., Murphy B. R., Collins P. L. 2001; Parainfluenza viruses. In Fields Virology , 4th edn. vol 1 pp 1341–1379 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
     [Google Scholar]
  6. Collins P. L., Chanock R. M., Murphy B. R. 1996; Respiratory syncytial virus. In Fields Virology , 4th edn. vol 1 pp 1443–1485 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
     [Google Scholar]
  7. De Swart R. L., Kuiken T., Timmerman H. H., van Amerongen G., van den Hoogen B. G., Vos H. W., Neijens H. J., Andeweg A. J., Osterhaus A. D. M. E. 2002; Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection. J Virol 76:11561–11569 [CrossRef]
     [Google Scholar]
  8. Durbin J. E., Durbin R. K. 2004; Respiratory syncytial virus-induced immunoprotection and immunopathology. Viral Immunol 17:370–380 [CrossRef]
     [Google Scholar]
  9. Ebihara T., Endo R., Ishiguro N., Nakayama T., Sawada H., Kikuta H. 2004a; Early reinfection with human metapneumovirus in an infant. J Clin Microbiol 42:5944–5946 [CrossRef]
     [Google Scholar]
  10. Ebihara T., Endo R., Kikuta H., Ishiguro N., Ishiko H., Hara M., Takahashi Y., Kobayashi K. 2004b; Human metapneumovirus infection in Japanese children. J Clin Microbiol 42:126–132 [CrossRef]
     [Google Scholar]
  11. Griffin D. E. 2001; Measles virus. In Fields Virology , 4th edn. vol 1 pp 1401–1441 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
     [Google Scholar]
  12. Hall C. B., Walsh E. E., Long C. E., Schnabel K. C. 1991; Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163:693–698 [CrossRef]
     [Google Scholar]
  13. Henderson F. W., Collier A. M., Clyde W. A., Denny F. W. 1979; Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med 300:530–534 [CrossRef]
     [Google Scholar]
  14. Herfst S., de Graaf M., Schickli J. H., Tang R. S., Kaur J., Yang C. F., Spaete R. R., Haller A. A. other authors 2004; Recovery of human metapneumovirus genetic lineages A and B from cloned cDNA. J Virol 78:8264–8270 [CrossRef]
     [Google Scholar]
  15. Kakuk T. J., Soike K., Brideau R. J., Zaya R. M., Cole S. L., Zhang J. Y., Roberts E. D., Wells P. A., Wathen M. W. 1993; A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. J Infect Dis 167:553–561 [CrossRef]
     [Google Scholar]
  16. Kuiken T., van den Hoogen B. G., van Riel D. A., Laman J. D., van Amerongen G., Sprong L., Fouchier R. A., Osterhaus A. D. 2004; Experimental human metapneumovirus infection of cynomolgus macaques ( Macaca fascicularis ) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol 164:1893–1900 [CrossRef]
     [Google Scholar]
  17. Leung J., Esper F., Weibel C., Kahn J. S. 2005; Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J Clin Microbiol 43:1213–1219 [CrossRef]
     [Google Scholar]
  18. MacPhail M., Schickli J. H., Tang R. S., Kaur J., Robinson C., Fouchier R. A. M., Osterhaus A. D. M. E., Spaete R. R., Haller A. A. 2004; Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J Gen Virol 85:1655–1663 [CrossRef]
     [Google Scholar]
  19. Maertzdorf J., Wang C. K., Brown J. B., Quinto J. D., Chu M., de Graaf M., van den Hoogen B. G., Spaete R. other authors 2004; Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol 42:981–986 [CrossRef]
     [Google Scholar]
  20. Morrow B. M., Hatherill M., Smuts H. E., Yeats J., Pitcher R., Argent A. C. 2006; Clinical course of hospitalised children infected with human metapneumovirus and respiratory syncytial virus. J Paediatr Child Health 42:174–178 [CrossRef]
     [Google Scholar]
  21. O'Doherty U., Swiggard W. J., Malim M. H. 2000; Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74:10074–10080 [CrossRef]
     [Google Scholar]
  22. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent end points. Am J Hyg 27:493–497
     [Google Scholar]
  23. Skiadopoulos M. H., Biacchesi S., Buchholz U. J., Riggs J. M., Surman S. R., Amaro-Carambot E., McAuliffe J. M., Elkins W. R. other authors 2004; The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J Virol 78:6927–6937 [CrossRef]
     [Google Scholar]
  24. Tang R. S., MacPhail M., Schickli J. H., Kaur J., Robinson C. L., Lawlor H. A., Guzzetta J. M., Spaete R. R., Haller A. A. 2004; Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys. J Virol 78:11198–11207 [CrossRef]
     [Google Scholar]
  25. Tang R. S., Mahmood K., MacPhail M., Guzzetta J. M., Haller A. A., Liu H., Kaur J., Lawlor H. A. other authors 2005; A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23:1657–1667 [CrossRef]
     [Google Scholar]
  26. van den Hoogen B. G., de Jong J. C., Groen J., Kuiken T., de Groot R., Fouchier R. A., Osterhaus A. D. 2001; A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7:719–724 [CrossRef]
     [Google Scholar]
  27. van den Hoogen B. G., van Doornum G. J., Fockens J. C., Cornelissen J. J., Beyer W. E., Groot R. R., Osterhaus A. D., Fouchier R. A. 2003; Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 188:1571–1577 [CrossRef]
     [Google Scholar]
  28. van den Hoogen B. G., Herfst S., Sprong L., Cane P. A., Forleo-Neto E., de Swart R. L., Osterhaus A. D., Fouchier R. A. 2004; Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10:658–666 [CrossRef]
     [Google Scholar]
  29. Wilkesmann A., Schildgen O., Eis-Hubinger A. M., Geikowski T., Glatzel T., Lentz M. J., Bode U., Simon A. 2006; Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr 165:467–475 [CrossRef]
     [Google Scholar]
  30. Williams J. V., Martino R., Rabella N., Otegui M., Parody R., Heck J. M., Crowe J. E., Jr. 2005; A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 192:1061–1065 [CrossRef]
     [Google Scholar]
  31. Williams J. V., Wang C. K., Yang C. F., Tollefson S. J., House F. S., Heck J. M., Chu M., Brown J. B. other authors 2006; The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis 193:387–395 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82663-0
Loading
Experimental infection of macaques with human metapneumovirus induces transient protective immunity
J. Gen. Virol. 88, 1251 (2007); https://doi.org/10.1099/vir.0.82663-0
/content/journal/jgv/10.1099/vir.0.82663-0
/content/journal/jgv/10.1099/vir.0.82663-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error